MARKET WIRE NEWS
  1. Home
  2. Stock
  3. RAPT
  4. News
RAPT
Quote
Short
News
Articles
Message Board

RAPT Therapeutics Inc. (NASDAQ : RAPT ) News

RAPT Therapeutics Inc. (NASDAQ: RAPT) News Releases

RAPT News Releases
RAPT : NASDAQ
SeekingAlpha
RAPT Therapeutics jumps on mid-stage data for urticaria candidate
RAPT : NASDAQ
24/7 Market News
FireSuites, Pharma, and FDA Fun
RAPT : NASDAQ
GlobeNewswire
RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria
RAPT : NASDAQ
GlobeNewswire
RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
RAPT : NASDAQ
GlobeNewswire
RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy
RAPT : NASDAQ
GlobeNewswire
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
RAPT : NASDAQ
US Earnings Reports
Expected earnings - RAPT Therapeutics Inc.
RAPT : NASDAQ
SeekingAlpha
RAPT Therapeutics GAAP EPS of -$0.65
RAPT : NASDAQ
GlobeNewswire
RAPT Therapeutics Reports Second Quarter 2025 Financial Results
RAPT : NASDAQ
GlobeNewswire
RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
Back to Start

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.